MAT2A was found as a synthetic lethal target in methylthioadenosine phosphorylase (MTAP)‐deficient cancer cells, and the mechanism involves SAM‐utilizing protein arginine methyltransferase 5 (PRMT5). Here, MAT2A is linked to cancer.